ABIGAIL POTHEN: Open Payments
NPI 1780217513 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 18 payments from 4 companies in 2025. Trend: 2023 $448 · 2024 $1,882 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $199 |
| Sumitomo Pharma America, Inc. | 6 | $170 |
| ABBVIE INC. | 6 | $120 |
| Ambu Inc. | 1 | $26 |
Products named: INTERSTIM, GEMTESA, BOTOX, LO LOESTRIN FE.
Industry payments across CA — which companies pay providers there.
